Status:
RECRUITING
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Lead Sponsor:
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Collaborating Sponsors:
Amsterdam UMC, location VUmc
Flevoziekenhuis
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Objectives: 1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection. 2. To determine immune response aberrations that are associated ...
Detailed Description
Sepsis will be defined in accordance with the current Sepsis 3.0 criteria as a(n) (suspected) infection with evidence of organ failure, as reflected by a SOFA (Sequential Organ Failure Assessment) sco...
Eligibility Criteria
Inclusion
- Age 18 years or higher
- Presentation at the Emergency Department (ED)
- Clinical suspicion of infection or earlier confirmed infection
- Modified Early Warning Score (MEWS) of 2 or higher
Exclusion
- No informed consent given
Key Trial Info
Start Date :
October 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
3300 Patients enrolled
Trial Details
Trial ID
NCT06178822
Start Date
October 25 2022
End Date
October 1 2026
Last Update
October 2 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Flevoziekenhuis
Almere Stad, Flevoland, Netherlands, 1315RA
2
Amsterdam UMC, location VUMC
Amsterdam, North Holland, Netherlands, 1081HZ
3
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands, 1105AZ